Nanotechnology and CRISPR/Cas-Mediated Gene Therapy Strategies: Potential Role for Treating Genetic Disorders
Molecular Biotechnology · 2025
DOI: 10.1007/s12033-024-01301-8 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Biotechnology, 2025. Verfasst von Guneet Kaur und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, Goswami Ganesh Dutta Sanatan Dharma College, Sector-32-C, Chandigarh, 160030, India. Hauptthemen laut MEDLINE: Genetic Therapy, CRISPR-Cas Systems, Nanotechnology, Genetic Diseases, Inborn. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 184 Literaturangaben.
Abstract (Originalsprache)
Gene therapy has made substantial progress in the treatment of the genetic diseases, focussing on the reduction of characteristics of recessive/dominant disorders, as well as various cancers. Extensive research has been conducted in the past few decades to investigate the application of nanotechnology and CRISPR/Cas technology in gene therapy. Nanotechnology due to attributes such has targeted drug delivery, controlled release, scalability and low toxicity has gained attention of the medical world. CRISPR/Cas9 system is considered as an impactful genome editing tool in the area of next-generation therapeutics and molecular diagnostics. CRISPR technology emphasises on gene editing, gene regulation modulation, and formulation of defined genetic changes. Its applications in treatment of the genetic disorders are extended beyond traditional therapies. These techniques are being explored as treatment of several genetic disorders including Duchenne muscular dystrophy, cystic fibrosis, Alzheimer's disease, Parkinson's disease, and Huntington disease. Despite considerable therapeutic potential of gene therapy, several obstacles must be addressed before it can be widely adopted in clinical practice, particularly in terms of ensuring safety and effectiveness. As research advances in this captivating field, these therapies will become the primary treatments and will have significant beneficial effects on the lives of patients with genetic disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biotechnology, Goswami Ganesh Dutta Sanatan Dharma College, Sector-32-C, Chandigarh, 160030, India.
- Department of Biotechnology, Goswami Ganesh Dutta Sanatan Dharma College, Sector-32-C, Chandigarh, 160030, India. batranavneet@gmail.com.
Zitieren
APA
Kaur, G., Arora, J., Sodhi, A. S., Bhatia, S., & Batra, N. (2025). Nanotechnology and CRISPR/Cas-Mediated Gene Therapy Strategies: Potential Role for Treating Genetic Disorders. Molecular Biotechnology. https://doi.org/10.1007/s12033-024-01301-8
Vancouver
Kaur G, Arora J, Sodhi AS, Bhatia S, Batra N. Nanotechnology and CRISPR/Cas-Mediated Gene Therapy Strategies: Potential Role for Treating Genetic Disorders. Molecular Biotechnology. 2025. doi:10.1007/s12033-024-01301-8
BibTeX
@article{Kaur2025,
author = {Kaur, Guneet and Arora, Jasnoor and Sodhi, Abhinashi Singh and Bhatia, Sonu and Batra, Navneet},
title = {Nanotechnology and CRISPR/Cas-Mediated Gene Therapy Strategies: Potential Role for Treating Genetic Disorders},
journal = {Molecular Biotechnology},
year = {2025},
doi = {10.1007/s12033-024-01301-8}
}
EUVIMED